Biotechnology in Asia-Pacific

March 2025 | 52 pages | ID: B701A7CEE3DFEN
MarketLine

Abstracts

Biotechnology in Asia-Pacific

Summary

Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• Biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications. Market value refers to the revenue generated from product sales, licensing fees, royalties, and research funding.
• The Asia-Pacific biotechnology market recorded revenues of $313.5 billion in 2024, representing a compound annual growth rate (CAGR) of 11.4% between 2019 and 2024.
• The medical/healthcare segment accounted for the market's largest proportion in 2024, with total revenues of $166.6 billion, equivalent to 53.1% of the market's overall value.
• In 2024, the Asia-Pacific biotechnology market recorded an annual growth of 6.5%. The growth is attributed to the expanding international collaborations and investments in the market.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
• Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts by both value and volume

Reasons to Buy

• What was the size of the Asia-Pacific biotechnology market by value in 2024?
• What will be the size of the Asia-Pacific biotechnology market in 2029?
• What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
• How has the market performed over the last five years?
• What are the main segments that make up Asia-Pacific's biotechnology market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the key players?
7.2. What strategies do the key players follow?
7.3. What have been the most recent market developments?

8 COMPANY PROFILES

8.1. Takeda Pharmaceutical Co Ltd
8.2. Astellas Pharma Inc
8.3. BeiGene Ltd
8.4. Kyowa Kirin Co Ltd
8.5. Chugai Pharmaceutical Co Ltd

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine